2023 Head & Neck Cancer Conference Guide Book
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
The RACE to overcome the crisis in<br />
<strong>Head</strong> and <strong>Neck</strong> cancers<br />
Oracle <strong>Cancer</strong> Trust<br />
Since Oracle was founded, we have funded over<br />
£8million of research projects. Our research<br />
focus is to provide support and funding for<br />
projects that result in better understanding,<br />
data and improved patient outcomes for those<br />
affected by <strong>Head</strong> and <strong>Neck</strong> cancers.<br />
<strong>Head</strong> and <strong>Neck</strong> cancers are the 4th most<br />
common cancer in men in the UK and the 7th<br />
overall. Around 12,400 people are diagnosed with<br />
a <strong>Head</strong> and <strong>Neck</strong> cancer each year with growing<br />
levels of late-stage diagnoses, low public<br />
awareness and poor rates of mortality.<br />
Patients are often left with debilitating<br />
appearance, speech, eating, swallowing and/or<br />
respiratory problems as well as psychological<br />
effects of loss of function and change in body<br />
image.<br />
Oracle <strong>Cancer</strong> Trust is the UK’s leading <strong>Head</strong> and<br />
<strong>Neck</strong> <strong>Cancer</strong> charity. Our mission is to improve<br />
<strong>Head</strong><br />
and <strong>Neck</strong> <strong>Cancer</strong> patient quality of life<br />
and outcomes in the UK.<br />
Our charity’s purpose and activities are all<br />
aimed at improving quality of life<br />
outcomes for <strong>Head</strong> and <strong>Neck</strong> cancer<br />
patients. To this end, Oracle <strong>Cancer</strong> Trust<br />
supports and runs 4 types of projects:<br />
Research projects: Oracle <strong>Cancer</strong> Trust<br />
supports research projects that<br />
demonstrate potential to deliver and<br />
drive greater understanding about <strong>Head</strong><br />
and <strong>Neck</strong> cancers, how best to treat<br />
them and where the greatest unmet<br />
needs are. This includes 1) lab-based<br />
medical research projects, 2) data<br />
gathering and analysis of disease and<br />
patient trends, and 3) qualitative and<br />
behavioural research projects.<br />
Awareness campaigns: Oracle <strong>Cancer</strong><br />
Trust drives, delivers and supports<br />
awareness campaigns focused on <strong>Head</strong><br />
and <strong>Neck</strong> cancers<br />
Collaboration programmes: Oracle<br />
<strong>Cancer</strong> Trust promotes and supports<br />
collaboration and creates key<br />
opportunities for knowledge sharing and<br />
agreeing best practice within <strong>Head</strong> and<br />
<strong>Neck</strong> cancers<br />
Experience of patients: Oracle <strong>Cancer</strong><br />
Trust will support, promote and<br />
encourage more focus and<br />
understanding on the patient experience<br />
within <strong>Head</strong> and <strong>Neck</strong> cancers.<br />
Oracle jointly funded a new study that suggests<br />
robotic surgery has high cure rates for some<br />
<strong>Head</strong> and <strong>Neck</strong> cancer patients. Published in<br />
the Journal of the National <strong>Cancer</strong> Institute,<br />
results from the RECUT study reveal that,<br />
following transoral robotic surgery (TORS), the<br />
two-year overall survival rate for recurrent head<br />
and neck cancer patients whose recurrence has<br />
been detected at an early stage is nearly three<br />
quarters (72%). This improves on other<br />
treatments currently available to this patient<br />
group, which often includes further<br />
radiotherapy or open surgery, in combination or<br />
alone, or chemotherapy and/or immunotherapy<br />
with palliative intent.<br />
Professor Vin Paleri, Project Lead<br />
RECUT study<br />
Get in touch<br />
oraclecancertrust.org<br />
+44 (0) 203 475 3471<br />
info@oraclecancertrust.org<br />
Support Oracle now, donate<br />
today!<br />
Scan here to donate:
Change language